| NCT ID | NCT06891092 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Bialystok |
| Condition | Cataract |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-01-01 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Comparison of the outcomes of bilateral implantation of extended depth of vision (EDOF) intraocular lenses (IOLs): the Rayone EMV and the Vivinex Impress XY1-EM in patients with cataract
Eligibility Criteria
Inclusion Criteria: * age-related bilateral cataract * age 21 or older * visual acuity \> 0.05 * axial length: 22.0 - 26.0 mm * normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant * written informed consent prior to surgery Exclusion Criteria: * active ocular disease (e.g. chronic severe uveitis, proliferative diabetic retinopathy, chronic glaucoma not responsive to medication) * relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX), intraoperative floppy iris syndrome (IFIS) * corneal decompensation or corneal endothelial cell insufficiency * previous ocular surgery or trauma * persons who are pregnant or nursing (pregnancy test will be taken in women of reproductive age) * corneal astigmatism \> 1 dpt. * retinopathies
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06891092 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 80 Years, studying Cataract. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06891092 currently recruiting?
Yes, NCT06891092 is actively recruiting participants. Contact the research team at joannakonopinska@o2.pl for enrollment information.
Where is the NCT06891092 trial being conducted?
This trial is being conducted at Bialystok, Poland.
Who is sponsoring the NCT06891092 clinical trial?
NCT06891092 is sponsored by Medical University of Bialystok. The trial plans to enroll 100 participants.